{"aiVersion":"1","content":{"id":"cmut49p1e0004hv71jmyt9a3d","slug":"understanding-myc-why-a-key-cancer-gene-is-hard-to-20261004","title":"Understanding MYC: Why a Key Cancer Gene Is Hard to Stop","level":"MEDIUM","publishedAt":"2026-10-04T01:02:49.893Z"},"topic":{"slug":"understanding-myc-why-a-key-cancer-gene-is-hard-to-20261004","category":"science"},"article":{"paragraphs":["Researchers have long studied the MYC gene because it is linked to many cancers. MYC has been implicated in about 70% of human cancers and is described as a master regulator of cell growth, metabolism, and division. Although it drives cancer, MYC has been called 'undruggable' because the protein is intrinsically disordered, lacks a clear binding pocket, and works in the cell nucleus where many drugs cannot reach. While small molecules have failed to bind MYC directly, scientists have developed alternative approaches that are being tested.","One strategy is to target DNA enhancers that increase MYC expression; in pediatric medulloblastoma, researchers have found an enhancer that drives MYC and can be disrupted. Other teams have shown that chromatin regulators control MYC amplification, offering epigenetic targets that could limit copy-number gains. New drug platforms such as PROTACs and engineered peptides (for example, Omomyc) have shown activity against MYC in lab models, and a biotech company recently treated the first patient in a Phase 2a trial of a MYC inhibitor. These efforts are early, but they have opened several paths to try to neutralize a gene long seen as untouchable."],"wordCount":188,"readTime":2},"vocabulary":[{"word":"gene","example":"The MYC gene controls many cell functions.","phonetic":"/dʒiːn/","definition":"A unit of heredity that contains instructions for making proteins."},{"word":"enhancer","example":"Blocking an enhancer lowered MYC expression in a tumor model.","phonetic":"/ɛnˈhænsər/","definition":"A DNA element that raises the activity of a gene."},{"word":"epigenetic","example":"Epigenetic drugs can change how genes like MYC are read.","phonetic":"/ˌɛp.ɪ.dʒəˈnɛtɪk/","definition":"Related to chemical changes that control gene activity without changing DNA."},{"word":"PROTAC","example":"Researchers design PROTACs to remove disease proteins.","phonetic":"/ˈproʊtæk/","definition":"A type of drug that marks proteins for destruction by the cell."}],"quiz":[{"answer":"about 70% of human cancers","question":"What percent of human cancers is MYC implicated in?"},{"answer":"because the protein is intrinsically disordered, lacks a clear binding pocket, and works in the cell nucleus","question":"Why has MYC been called 'undruggable'?"},{"answer":"treated the first patient in a Phase 2a trial","question":"What clinical action did a biotech company recently take?"}],"discussion":[{"question":"Do you think research news about early drug trials gives hope? Why?"},{"question":"Have you ever known someone affected by cancer research advances? What changed?"},{"question":"What do you think about drugs that work indirectly (not on the main protein)?"},{"question":"Would you be interested in learning more about how DNA 'enhancers' work?"}]}